Abstract

In this chapter, Zahra Meghani provides a brief overview of the regulatory framework for consumer products in the United States, the European Union and Japan, followed by an extended analysis of their regulation of genetically modified food. The regulatory regimes for GM food of the three regions differ substantially, but they are committed to the same model of scientific risk assessment. That paradigm assumes that risk evaluations are not influenced by any normative concerns. This chapter critiques that conception of risk assessment. It is argued that in the interest of presenting to the public an accurate account of their work, the regulatory entities of the US, the EU, and Japan should acknowledge that their risk assessment of GM food involve normative choices. Moreover, they should create open, transparent, democratic processes to include the public in the deliberations and decision-making about the values that should shape the risk evaluation of GM foods at every stage of the risk assessment process.